ALT levels were above the norm in 10.37% (n=17) of the subjects without carbohydrate metabolism disorders, 15.00% (n=3) of the IGT group and 33.33% (n=2) of the IFG group. The gene discussed is GPT; the disease is carbohydrate metabolism disease.